Instrumentation Laboratory's blood clot test approved in US and Canada
This article was originally published in Clinica
The US FDA has granted 510(k) clearance for Instrumentation Laboratory's HemosIL D-Dimer HS 500 assay. The test is designed to rule out venous thromboembolism in cases of suspected deep vein thrombosis and pulmonary embolism. Health Canada has also approved the product, which provides results in five minutes. It measures levels of D-dimer in patients' citrated plasma, a fragment present in the blood after a blood clot has broken down. Studies have found it has a 100% negative predictive value, Instrumentation Laboratory (Bedford, Massachusetts) claims. The firm will commercialise the test in the US with its distribution partner, Beckman Coulter. The assay was launched in Europe in April 2009.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.